ArticleMolecular neurobiology2025
FOXP2-Dependent Vulnerability of RGCs Under Acute Ocular Hypertension.
Article in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Acute angle-closure glaucoma leads to a rapid rise in intraocular pressure. Ocular hypertension (OHT) compresses the optic nerve head and causes degeneration of retinal ganglion cells (RGCs). RGC subtypes exhibit different susceptibility to OHT. This study aimed to determine whether the selective vulnerability of RGCs is related to Foxp2, a critical gene in neurodevelopmental disorders and neurodegeneration. Acute OHT increased apoptotic cell death of RGCs and reduced the ratio of FOXP2-positive RGCs (F-RGCs) to the total RGCs, suggesting a higher proportional loss of F-RGCs compared to average non-F-RGCs. Retina-specific knockout (KO) of Foxp2 in mice mitigated the excessive reduction of F-RGCs and degeneration of RGC axons (blebbing) caused by acute OHT. Furthermore, F-RGCs had an increased expression of dynactin-1, and their soma received retrograde labeling from the superior colliculus at a slower rate than the non-F-RGCs, suggesting that FOXP2 may impair the dynactin/dynein-mediated axoplasmic transport in RGCs. The data support that Foxp2 contributes to increased vulnerability of RGCs to OHT-induced damage, at least in part by slowing axonal transport. This study sheds light on the molecular mechanisms governing RGCs' selective vulnerability and provides insights into potential strategies to protect these cells from OHT in glaucoma.
Indexed as
Identifiers
41272339What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.